HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadashi Terada Selected Research

Ki-67 Antigen (Ki 67 Antigen)

1/2013An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.
1/2013Multiple cytokeratin-negative malignant tumors composed only of rhabdoid cells in the renal pelvis: a sarcomatoid urothelial carcinoma?
1/2013Small cell carcinoma of the oral cavity (cheek mucosa): a case report with an immunohistochemical and molecular genetic analysis.
1/2013Primary cutaneous neuroendocrine tumor (atypical carcinoid) expressing KIT and PDGFRA with myoepithelial differentiation: a case report with immunohistochemical and molecular genetic studies.
1/2013Primary small cell carcinoma of the stomach: a case report with an immunohistochemical and molecular genetic analysis.
3/2011Clear cell adenocarcinoma of the uterine cervix in a young pregnant woman: a case report with immunohistochemical study.
6/2010Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA.
1/2010Small cell carcinoma of the brain without extracranial involvement by serial CT, MRI and PET.
1/2009Intraductal tubular carcinoma, intestinal type, of the pancreas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadashi Terada Research Topics

Disease

93Neoplasms (Cancer)
10/2020 - 06/2002
25Carcinoma (Carcinomatosis)
01/2014 - 11/2003
20Adenocarcinoma
01/2013 - 07/2005
10Neoplasm Metastasis (Metastasis)
01/2015 - 05/2003
8Small Cell Carcinoma
01/2015 - 04/2009
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2013 - 04/2009
6Signet Ring Cell Carcinoma
01/2013 - 02/2009
5Cysts
01/2013 - 10/2003
4Ulcer
01/2013 - 03/2011
3Amyloidosis
08/2015 - 11/2009
3Metaplasia
01/2013 - 09/2010
3Melanoma (Melanoma, Malignant)
01/2012 - 10/2010
3Renal Cell Carcinoma (Grawitz Tumor)
01/2012 - 10/2010
3Carcinoid Tumor (Carcinoid)
01/2012 - 11/2010
2Clear Cell Adenocarcinoma
09/2014 - 03/2011
2Polyps
01/2013 - 03/2011
2Adenoma (Adenomas)
01/2013 - 03/2011
2Cholangiocarcinoma
01/2013 - 06/2002
2Myoepithelioma
01/2013 - 02/2011
2Neuroblastoma
01/2012 - 04/2011
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2012 - 10/2011
2Sarcoma (Soft Tissue Sarcoma)
06/2011 - 02/2010
2Pancreatitis
03/2011 - 11/2002
2Granular Cell Tumor
10/2010 - 04/2009
2Hepatocellular Carcinoma (Hepatoma)
10/2010 - 11/2002
2Transitional Cell Carcinoma
06/2010 - 11/2009
1Immunoglobulin Light-chain Amyloidosis
08/2015
1Glioblastoma (Glioblastoma Multiforme)
07/2015
1Adenomyoma
02/2015

Drug/Important Bio-Agent (IBA)

48VimentinIBA
02/2015 - 01/2008
39Keratins (Keratin)IBA
07/2015 - 01/2008
38SynaptophysinIBA
01/2015 - 11/2002
38Proteins (Proteins, Gene)FDA Link
01/2015 - 06/2002
34S100 Proteins (S 100 Protein)IBA
10/2014 - 01/2008
29ChromograninsIBA
01/2015 - 01/2009
27Phosphopyruvate Hydratase (Enolase)IBA
01/2015 - 01/2009
26CAM 5.2 antigenIBA
02/2015 - 01/2011
25AntigensIBA
03/2015 - 02/2004
24DesminIBA
10/2014 - 12/2008
16ElementsIBA
01/2013 - 02/2009
15Mucin-1 (CA 15-3 Antigen)IBA
05/2014 - 11/2003
15MucinsIBA
01/2013 - 08/2003
11MyoglobinIBA
10/2014 - 11/2009
9Ki-67 Antigen (Ki 67 Antigen)IBA
01/2013 - 01/2009
8von Willebrand FactorIBA
01/2013 - 01/2009
8Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2012 - 01/2009
6Platelet-Derived Growth FactorIBA
01/2015 - 01/2011
6Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
10/2014 - 01/2012
6Carcinoembryonic AntigenIBA
07/2013 - 11/2002
5Progesterone Receptors (Progesterone Receptor)IBA
03/2011 - 12/2008
5Estrogen ReceptorsIBA
03/2011 - 12/2008
5Capsules (Microcapsules)IBA
12/2010 - 05/2003
4Fetal Proteins (Fetoprotein)IBA
04/2012 - 10/2010
4CarbohydratesIBA
04/2011 - 02/2004
3Coloring Agents (Dyes)IBA
08/2015 - 11/2009
3Congo RedIBA
08/2015 - 11/2009
3Prostate-Specific Antigen (Semenogelase)IBA
01/2015 - 09/2011
3GlycogenIBA
09/2014 - 03/2011
3Calbindin 2IBA
05/2014 - 12/2010
3Immunoglobulin G (IgG)IBA
02/2012 - 11/2009
3Immunoglobulin A (IgA)IBA
02/2012 - 11/2009
3Immunoglobulin M (IgM)IBA
02/2012 - 11/2009
3Glial Fibrillary Acidic ProteinIBA
01/2012 - 11/2009
3Glucagon (Glukagon)FDA Link
11/2010 - 02/2009
2Keratin-5 (Keratin 5)IBA
10/2020 - 12/2010
2Eosine Yellowish-(YS) (Eosin)IBA
10/2014 - 10/2010
2Hematoxylin (Haematoxylon)IBA
10/2014 - 10/2010
2Serotonin (5 Hydroxytryptamine)IBA
05/2014 - 11/2010
2B72.3 antibodyIBA
05/2014 - 12/2010
2Chromogranin AIBA
03/2013 - 11/2011
2CholesterolIBA
01/2013 - 10/2003
2Anti-Bacterial Agents (Antibiotics)IBA
01/2013 - 01/2012
2GalliumIBA
01/2013 - 03/2011
2Melanins (Melanin)IBA
10/2012 - 01/2012
2Cyclin D1IBA
02/2012 - 11/2002
2Apoprotein(a) (Apolipoprotein (a))IBA
01/2012 - 12/2011
2Surface-Active Agents (Surfactants)IBA
01/2012 - 12/2011
2Codon (Codons)IBA
10/2011 - 01/2009
2ParaffinIBA
10/2011 - 10/2010
2AmylasesFDA Link
03/2011 - 01/2009
2CD34 Antigens (CD34 Antigen)IBA
03/2011 - 01/2009
2Calmodulin-Binding Proteins (Caldesmon)IBA
02/2011 - 12/2010
2Cisplatin (Platino)FDA LinkGeneric
01/2011 - 01/2010
2GastrinsIBA
11/2010 - 12/2009
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2010 - 12/2009
2Keratin-7 (Cytokeratin 7)IBA
11/2010 - 09/2010
2BilirubinIBA
05/2010 - 08/2003
2Lipase (Acid Lipase)FDA Link
01/2009 - 02/2004

Therapy/Procedure

13Drug Therapy (Chemotherapy)
01/2015 - 07/2008
5Salpingo-oophorectomy
07/2012 - 07/2005
4Nephrectomy
01/2014 - 01/2010
4Hysterectomy
01/2013 - 07/2005
3Cholecystectomy
01/2013 - 11/2003
3Oral Diagnosis (Oral Examination)
01/2012 - 09/2011
3Laparotomy
06/2011 - 07/2008
2Prostatectomy (Retropubic Prostatectomy)
07/2012 - 01/2011
2Cystectomy
01/2012 - 11/2009
2Appendectomy
08/2009 - 04/2009
2Therapeutics
04/2009 - 05/2003
1Uterine Myomectomy
02/2015